MPMeditrine s.r.o.
- Address
- Opavska 962/39, 708 00 Poruba, Czechia
MPMeditrine s.r.o. - Neuropsychiatric Research Center
MPMeditrine s.r.o. is a specialized clinical research facility focused on advancing treatments for complex neuropsychiatric and movement disorders. The center demonstrates particular expertise in conducting phase III clinical trials and long-term safety studies for novel therapeutic interventions targeting cognitive and psychiatric disorders that significantly impact patients' quality of life.
- Schizophrenia and cognitive impairment associated with psychotic disorders
- Treatment-resistant depression and innovative psychedelic-assisted therapies
- Tardive dyskinesia and movement disorders secondary to psychiatric treatments
The research center plays a crucial role in evaluating both efficacy and long-term safety profiles of investigational medications, including extension studies that monitor patients beyond initial treatment periods. Their involvement in studies examining COMP360 for treatment-resistant depression and vesicular monoamine transporter 2 (VMAT2) inhibitors for tardive dyskinesia demonstrates their commitment to exploring cutting-edge therapeutic approaches. MPMeditrine's expertise encompasses randomized, double-blind, placebo-controlled trials as well as open-label safety studies, positioning them as a comprehensive partner in neuropsychiatric drug development.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Adeptio Pharmaceuticals Limited2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Adeptio Pharmaceuticals Limited2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MPMeditrine s.r.o.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DT-101 in Adults with Major Depressive Disorder | Draig Therapeutics Limited | Phase II | Recruiting | Mar 2026 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol | 2 | Unknown | 2023-11-13 | 2024-04-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.